Simpler language, slower speech may improve lupus medication adherence

Sumary of Simpler language, slower speech may improve lupus medication adherence:

• Optimizing patient-provider communication and enhancing patient self-efficacy may improve medication adherence rates among patients with systemic lupus erythematosus, according to results presented at the ACR Convergence 2020 meeting..
• “We found that persistent nonadherence, a subset of nonadherent patients, is disproportionately more common in young Black patients..
• An important strength of our study is that we assess adherence at two separate time points to find a particularly high-risk group of patients.”.
• “Our results suggest that optimizing patient provider communication and patient self-efficacy and medication management are potential avenues for intervention in this particularly high-risk group.”.
• Adobe Stock Barr and colleagues conducted a longitudinal survey and chart review to identify modifiable risk factors for medication nonadherence among patients with SLE..
• To do this, the researchers identified patients with SLE enrolled in the Duke Registry who were taking one or more medications for their disease..
• Baseline data were collected between July 2018 and January 2019, and included demographics, self-efficacy, patient-provider communication according to the Interpersonal Processes of Care survey, and Systemic Lupus International Collaborating Clinics (SLICC) damage scores..
• At both baseline and follow-up, adherence data were collected, including self-reported adherence in the previous month from 0 to 100% (90% = high self-reported adherence), and pharmacy refill data in the previous 3 months (80% medication adherence ratio = high refills), with both high self-reported adherence and high refills equating to high composite adherence..
• Persistent adherence was defined as patients with high composite adherence at both baseline and follow-up, and persistent nonadherence was defined as those with low composite adherence at baseline and follow-up..
• At baseline, 73% of patients had high self-reported adherence, 51% had high refills and 43% had high persistent adherence…

Want to know more click here go to health news source.

From Healio - November 8, 2020